Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1970 May;1(5):427–430. doi: 10.1128/iai.1.5.427-430.1970

Increased Resistance of Pseudomonas aeruginosa to Carbenicillin After Reversion from Spheroplast to Rod Form 1

Chatrchai Watanakunakorn a, John P Phair a, Morton Hamburger a
PMCID: PMC415919  PMID: 16557753

Abstract

Five of six strains of Pseudomonas aeruginosa had at least fourfold increase in resistance to carbenicillian after they reverted from carbenicillin-induced spheroplasts to rod forms. The most susceptible laboratory strain showed the greatest increase in resistance. There was a marked inoculum effect on the minimal inhibitory concentration of carbenicillin when high inocula (107 colony-forming units) or very low inocula (102 or 103 colony-forming units) were used. Population analysis of this reverted strain revealed increase in resistance of the entire population of cells to carbenicillin. However, the degree of resistance was not homogenous. Only a few cells were highly resistant. Comparison of the effect of carbenicillin on the growth of the parent and reverted strains confirmed the increase in resistance of the reverted strain. The resistance remained stable after 42 passages.

Full text

PDF
427

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Acred P., Brown D. M., Knudsen E. T., Rolinson G. N., Sutherland R. New semi-synthetic penicillin active against Pseudomonas pyocyanea. Nature. 1967 Jul 1;215(5096):25–30. doi: 10.1038/215025a0. [DOI] [PubMed] [Google Scholar]
  2. Bell S. M., Smith D. D. Resistance of Pseudomonas aeruginosa to carbenicillin. Lancet. 1969 Apr 12;1(7598):753–754. doi: 10.1016/s0140-6736(69)91754-1. [DOI] [PubMed] [Google Scholar]
  3. Bodey G. P., Rodriguez V., Luce J. K. Carbenicillin therapy of gram-negative bacilli infections. Am J Med Sci. 1969 Jun;257(6):408–414. doi: 10.1097/00000441-196906000-00007. [DOI] [PubMed] [Google Scholar]
  4. Boxerbaum B., Doershuk C. F., Pittman S., Matthews L. W. Efficacy and tolerance of carbenicillin in patients with cystic fibrosis. Antimicrob Agents Chemother (Bethesda) 1968;8:293–295. [PubMed] [Google Scholar]
  5. Brumfitt W., Percival A., Leigh D. A. Clinical and laboratory studies with carbenicillin. A new penicillin active against Pseudomonas pyocyanea. Lancet. 1967 Jun 17;1(7503):1289–1293. doi: 10.1016/s0140-6736(67)91590-5. [DOI] [PubMed] [Google Scholar]
  6. DARRELL J. H., WAHBA A. H. PYOCINE-TYPING OF HOSPITAL STRAINS OF PSEUDOMONAS PYOCYANEA. J Clin Pathol. 1964 May;17:236–242. doi: 10.1136/jcp.17.3.236. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Darrell J. H., Waterworth P. M. Carbenicillin resistance in Pseudomonas aeruginosa from clinical material. Br Med J. 1969 Jul 19;3(5663):141–143. doi: 10.1136/bmj.3.5663.141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gillies R. R., Govan J. R. Typing of Pseudomonas pyocyanea by pyocine production. J Pathol Bacteriol. 1966 Apr;91(2):339–345. doi: 10.1002/path.1700910207. [DOI] [PubMed] [Google Scholar]
  9. HAIGHT T. H., FINLAND M. Modified Gots test for penicillinase production. Am J Clin Pathol. 1952 Aug;22(8):806–808. doi: 10.1093/ajcp/22.8_ts.806. [DOI] [PubMed] [Google Scholar]
  10. Jones R. J., Lowbury E. J. Prophylaxis and therapy for Pseudomonas aeruginosa infection with carbenicillin and with gentamicin. Br Med J. 1967 Jul 8;3(5557):79–82. doi: 10.1136/bmj.3.5557.79. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Knudsen E. T., Rolinson G. N., Sutherland R. Carbenicillin: a new semisynthetic penicillin active against Pseudomonas pyocyanea. Br Med J. 1967 Jul 8;3(5557):75–78. doi: 10.1136/bmj.3.5557.75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Lowbury E. J., Lilly H. A., Kidson A., Ayliffe G. A., Jones R. J. Sensitivity of Pseudomonas aeruginosa to antibiotics: emergence of strains highly resistant to carbenicillin. Lancet. 1969 Aug 30;2(7618):448–452. doi: 10.1016/s0140-6736(69)90163-9. [DOI] [PubMed] [Google Scholar]
  13. Phair J. P., Watanakunakorn C., Bannister T. In vitro susceptibility of Pseudomonas aeruginosa to carbenicillin and the combination of carbenicillin and gentamicin. Appl Microbiol. 1969 Sep;18(3):303–306. doi: 10.1128/am.18.3.303-306.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Richardson A. E., James K. W., Spittle C. R., Robinson O. P. Experiences with carbenicillin in the treatment of septicaemia and meningitis. Postgrad Med J. 1968 Nov;44(517):844–847. doi: 10.1136/pgmj.44.517.844. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Silverblatt F., Turck M. Laboratory and clinical evaluation of carbenicillin (carboxybenzyl penicillin). Antimicrob Agents Chemother (Bethesda) 1968;8:279–285. [PubMed] [Google Scholar]
  16. Smith C. B., Finland M. Carbenicillin: activity in vitro and absorption and excretion in normal young men. Appl Microbiol. 1968 Nov;16(11):1753–1760. doi: 10.1128/am.16.11.1753-1760.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Standiford H. C., Kind A. C., Kirby W. M. Laboratory and clinical studies of carbenicillin against gram-negative bacilli. Antimicrob Agents Chemother (Bethesda) 1968;8:286–291. [PubMed] [Google Scholar]
  18. Stephenson J. B. Resistance of Pseudomonas aeruginosa. Lancet. 1969 May 31;1(7605):1098–1099. doi: 10.1016/s0140-6736(69)91734-6. [DOI] [PubMed] [Google Scholar]
  19. Stratford B. C. The treatment of infections due to Pseudomonas aeruginosa with carbenicillin ("Pyopen"). Med J Aust. 1968 Nov 16;2(20):890–895. doi: 10.5694/j.1326-5377.1968.tb83274.x. [DOI] [PubMed] [Google Scholar]
  20. WAHBA A. H. THE PRODUCTION AND INACTIVATION OF PYOCINES. J Hyg (Lond) 1963 Dec;61:431–441. doi: 10.1017/s0022172400021057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Watanakunakorn C., Hamburger M. Induction of spheroplasts of Pseudomonas aeruginosa by carbenicillin. Appl Microbiol. 1969 Jun;17(6):935–937. doi: 10.1128/am.17.6.935-937.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES